Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

NCT00077103 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
DRUG: cisplatin
DRUG: doxorubicin hydrochloride
DRUG: fosbretabulin disodium
RADIATION: radiation therapy

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]